QMS Medical Allied Services Limited (QMSMEDI)
Updates
Standalone FY2025-26 results:
- Revenue 15,265m +5.1% y-y; EBITDA 2,085m -12.3% y-y; PAT 669m -35.8% y-y
- Consolidated FY2025-26 revenue 17,393m +10.8% y-y; EBITDA 2,693m -0.7% y-y; PAT 1,192m -13.0% y-y
- Board recommended final dividend Re 0.50/share (5%) for FY2025-26
- Rights issue raised 1,204.8m; increased subsidiary stake to 76%
- Migration to NSE Mainboard effective 18-Jun-2026
- 12 board meetings held with full attendance
- No material regulatory or legal issues reported
- CSR spend Rs 22.07m in FY2025-26
- Net debt stable; finance costs increased
- EPS standalone 3.56, consolidated 5.40
- Management confident on growth opportunities in healthcare services and product distribution
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 QMSMEDI — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add QMSMEDI to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on QMS Medical Allied Services Limited
Important.
The summary above is generated automatically from QMS Medical Allied Services Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.